Page last updated: 2024-11-02

pioglitazone and Carcinoma, Ehrlich Tumor

pioglitazone has been researched along with Carcinoma, Ehrlich Tumor in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Sisi, AE1
Sokar, SS1
Salem, TA1
Abu Risha, SE1

Other Studies

1 other study available for pioglitazone and Carcinoma, Ehrlich Tumor

ArticleYear
PPARĪ³-dependent anti-tumor and immunomodulatory actions of pioglitazone.
    Journal of immunotoxicology, 2015, Volume: 12, Issue:4

    Topics: Animals; Apoptosis; Carcinoma, Ehrlich Tumor; Doxorubicin; Female; Gene Expression Regulation, Neopl

2015